- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07631078
kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot
kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery
kTMP, kilohertz transcutaneous magnetic perturbations, is a low intensity transcranial magnetic stimulation technique that will be used in this study to promote arm/hand rehabilitation in patients who have been disabled by stroke.
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
The goal of this pilot clinical trial is to assess the feasibility and preliminary efficacy of kTMP on upper limb motor recovery in chronic stroke compared to sham. We will conduct a 6-week double-blind, randomized, sham-controlled pilot study to test the beneficial influence of kTMP combined with simple motor tasks on kinematic outcomes such as range of motion of the upper arm, hand and fingers.
After baseline assessments, participants will be randomly allocated to either the kTMP group or the Control group. Participants, experimentalists, and outcome assessors will be blinded to group allocation. kTMP will begin within 1 week following randomization and will be delivered three times a week for 6 weeks. The primary endpoint will be assessed at the end of treatment, with follow-up assessments occurring 1 month, 3 months and 6 months following treatment completion. There is one assessment 4 weeks into the treatment phase to assess if patients continue to improve from 4 to 6 weeks of treatment.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Ludovica Labruna, PhD
- Telefonní číslo: 5104237125
- E-mail: participate@magnetictides.com
Studijní místa
-
-
California
-
San Francisco, California, Spojené státy, 94158
- Nábor
- UCSF Mission Bay- Sandler Neurosciences Center
-
Kontakt:
- Christina Merrick
- Telefonní číslo: 510-423-7125
- E-mail: participate@magnetictides.com
-
Vrchní vyšetřovatel:
- Ludovica Labruna, PhD
-
Vrchní vyšetřovatel:
- Richard Ivry, PhD
-
Vrchní vyšetřovatel:
- Karunesh Ganguly, MD
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion criteria:
- Adults aged 18-80 years who have a history of an ischemic or hemorrhagic stroke ≥ 12 m prior to enrollment.
- Fugl-Meyer Assessment: Upper Extremity (FMA UE) score 20-50.
- Ability to communicate, understand, and give appropriate consent. Participants can follow two-step commands.
- Motor evoked potentials in a hand muscle when stimulating ipsilesional cortex with suprathreshold single-pulse TMS (MEP positive).
Exclusion criteria:
- Participants with moderate or severe cognitive impairment (MMSE < 18).
- Participants with sensory deficits FMA-S < 6/12 (with proprioception < 4/8).
- Participants with severe apraxia (TULIA < 5).
- Language impairment or behavioral disorder that interferes with their ability to adhere to the protocol or to provide informed consent.
- Individuals who have a serious uncontrolled medical condition, including but not limited to severe cardiovascular and cardiopulmonary disease.
- Pregnancy or plans to become pregnant during the study period.
- Botulinum toxin injections of the affected upper extremity within 3 months prior to onset of study.
- Severe spasticity of the affected upper limb (Modified Ashworth ≥ 4).
- Absolute contraindications related to non-invasive brain stimulation, including:
9a) History of seizures in the last 12 months while taking anti-epilepsy medication 9b) Presence of any metal implants in the head (excluding the mouth), such as cortical stimulators and DBS, clips, coils, shunts, stents or skull plates, cochlear implants 9c) Permanent eye liner or head tattoos 9d) Implanted electronics such as pacemakers, defibrillators, intrathecal baclofen pumps or vagus nerve stimulator 9e) History of experiencing a serious adverse event during a previous transcranial magnetic stimulation (TMS) session
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Trojnásobný
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Active kTMP
Participants received 8 V/m of active stimulation |
A new non-invasive brain stimulation tool |
|
Falešný srovnávač: Sham kTMP
Participants receive sham stimulation (0.0 V/m electric field) |
A new non-invasive brain stimulation tool with sham setting selected |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Movement Quality Index (MQI)
Časové okno: Enrollment, then weeks 4, 6, 10, 18, 30
|
Kinematic data will be captured using a markerless, three-camera motion tracking system during a standardized reach-to-grasp task, with 30 trials per assessment. The cameras will reconstruct 3D hand, arm, and shoulder motion. The primary outcome is change from baseline in the Movement Quality Index (MQI), compared between kTMP and sham groups. MQI is a composite kinematic score calculated as range of motion (ROM) divided by trial-to-trial variability (T2TV), both derived from the 3D reconstructions: ROM: range, speed, and smoothness of hand/arm motion, including elbow and shoulder joint angles. T2TV: consistency across trials, measured as variance of 3D trajectories around the mean trajectory. |
Enrollment, then weeks 4, 6, 10, 18, 30
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Fugl- Meyer Assessment (Upper Extremity) FMA-UE
Časové okno: Enrollment, then weeks 4, 6, 10, 18, 30
|
The Fugl-Meyer Assessment (FMA) is a structured evaluation used to measure motor recovery after a stroke, with a total score range of 0-226. Higher scores indicate better motor function, while lower scores reflect greater impairment. |
Enrollment, then weeks 4, 6, 10, 18, 30
|
|
Modified Ashworth Scale (MAS)
Časové okno: Enrollment, then weeks 4, 6, 10, 18, 30
|
Test of resistance to passive movement about a joint, scores range from 0 to 5 where 0=no increase in muscle tone and 5=affected part(s) rigid. Hight scores indicate greater muscle tone. |
Enrollment, then weeks 4, 6, 10, 18, 30
|
|
Stroke Impact Scale (SIS)
Časové okno: Enrollment, then weeks 4, 6, 10, 18, 30
|
Self reported questionnaire that evaluates disability and health related quality of life after stroke, consisting of 59 items, assessing strength, hand function, ADL/iADL, mobility, communication, emotion, memory and thinking, participation/role function. Each item is rated in a 5 point Likert scale, where 1 equals could not do it at all and 5 equals not difficult at all. Score ranges 0-100. Higher score indicates less disability and high quality of life after stroke. |
Enrollment, then weeks 4, 6, 10, 18, 30
|
|
EuroQOL (EQ-5D)
Časové okno: Enrollment, then weeks 4, 6, 10, 18, 30
|
A health questionnaire that measures 5 dimensions including mobility, self-care, usual activities, pain/discomfort, anxiety/depression. Each item is described by 3 levels of problems, where 1=none, 2=mild to moderate, and 3=severe. This provides a simple single index value for health status, where a higher score indicates worse health state. |
Enrollment, then weeks 4, 6, 10, 18, 30
|
|
Motor Activity Log (MAL)
Časové okno: Enrollment, then weeks 4, 6, 10, 18, 30
|
Self reported perception of Quality of movement are rated in 30 functional tasks, scored on a 6 point ordinal scale where 0=weaker arm not used at all for that activity and 5=ability to use the weaker arm for that activity is as good as before the stroke(normal). A higher score indicates better quality upper extremity movement. |
Enrollment, then weeks 4, 6, 10, 18, 30
|
|
Wolf Motor Function Test (WMFT)
Časové okno: Enrollment, then weeks 4, 6, 10, 18, 30
|
A quantitative measure of upper extremity motor abilitythrough timed and functional tasks will be administered by a trained experimenter. |
Enrollment, then weeks 4, 6, 10, 18, 30
|
|
Stroke Specific QOL (SSQOL)
Časové okno: At enrollment, then weeks 4, 6, 10, 18, and 30
|
Questionnaire consisting of 49 items in the 12 domains of mobility, energy, upper extremity function, work and productivity, mood, self-care, social roles, family roles, vision, language, thinking and personality. Each item is assessed on a 5 point Guttman type scale, where 1=total help; couldn't do it at all; strongly agree and 5 =no help needed; no trouble at all; strongly disagree. Higher scores indicate better functioning. |
At enrollment, then weeks 4, 6, 10, 18, and 30
|
Spolupracovníci a vyšetřovatelé
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
- Mrtvice
- Transkraniální magnetická stimulace
- Cévní mozková příhoda
- Neinvazivní mozková stimulace
- Kortikální vzrušivost
- Chronická mrtvice
- Plastičnost
- Cerebrovaskulární poruchy
- Poruchy mozku
- Poruchy centrálního nervového systému
- Hemoragická mrtvice
- Kardiovaskulární poruchy
- kTMP
- kilohertz transkraniální magnetická perturbace
Další relevantní podmínky MeSH
Další identifikační čísla studie
- kTMPstrokePilot
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
produkt vyrobený a vyvážený z USA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .